The nation of Zimbabwe has rejected a major US healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to the United States' request for confidential information.
The decision became public following a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
A government spokesperson later explained that the United States was demanding access to health data for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from any future medical innovations.
"We will now turn to the difficult and regrettable task of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued dialogue to reach a deal acceptable to both sides so the country's critical HIV programme can continue.
Wider Background
This development comes after a similar case in Kenya, where a high court halted a similar deal with the US following concerns were filed about the security of citizens' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and accountability.
As per reports, 16 African countries have to date signed these new agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no corresponding assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," he stated.
"Put simply, our country would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our people if a future disease outbreak arise."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining frameworks already established through the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This system is intended to guarantee that when a nation contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage continued discussions with our US partners on how subsequent collaboration might be arranged in a manner that respects the independence and dignity of both nations."
Medical Community Reaction
Medical experts expressed it recognised the official position, but recommended that talks should continue given that a large portion of the nation's Aids initiatives depended on international support.
"In cases where technical issues exist, such as those involving information security or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," the group added.
This impasse underscores the ongoing tensions between receiving much-needed international aid and safeguarding local interests in an ever more data-driven world.